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Oligonucleotide-directed gene alteration produces a targeted DNA sequence change in the genome of mammalian
cells. The advantage of this approach is that expression of the corrected gene is regulated in the same way as a
normal gene. Reliable, sensitive, and standardized assays played a critical role in the measurement of gene cor-
rection frequency among different cell types and in evaluating the structure–activity relationship of oligonucleo-
tides. Mechanistic studies using these assays have become critical for understanding the gene repair process and
setting realistic expectations on the capability of this technology. The epidermis is an ideal tissue where oligonuc-
leotides can be administered locally and the treated sites can be monitored easily. But given the low frequency of
gene correction, general selection procedures and ampliﬁcation of corrected cells via epidermal stem cells are
ultimately needed to make the gene repair technology practical. Recent data suggest that the in vivo application of
oligonucleotides may be capable of gene correction in epidermal stem cells and the subsequent expansion of the
corrected cells may result in an apparent high-level and long-lasting gene repair. Advances in oligonucleotide
delivery and targeting of epidermal stem cells will be required for potential application of oligonucleotides toward
treatment of genodermatoses.
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Genetic defects in human cells can be corrected by gene
therapy in two ways, gene replacement and gene targeting.
In gene replacement therapy, a therapeutic gene is trans-
ferred to the cell or affected organ usually by virus-mediated
gene transfer. But expression of the transferred gene is
constitutive and unregulated, a situation that may be harm-
ful in certain cases. Moreover, gene replacement cannot
rescue a dominant mutation and the use of viral vectors
presents safety concerns including immune reactions and
the generation of replication competent virus. In contrast,
gene targeting is designed to produce pre-defined altera-
tions in the genome. By repairing the mutant gene in situ,
normal gene regulation is preserved and the potential is
there to treat dominant disorders.
Several gene-targeting strategies have been developed
to correct mutations through homologous recombination
process (Table I). Through the use of traditional gene-tar-
geting strategies via double-stranded DNA, it has become
possible to replace or delete genetic information in chro-
mosomes (Thomas and Capecchi, 1987; Mansour et al,
1988; Capecchi, 1989). The application of this strategy to
embryonic stem cells, however, has been possible by se-
lecting rare successful targeting products. In another
approach, triple-helix-forming oligonucleotides (TFO) have
been utilized to make a specific sequence change in the
genome by exploiting its specific recognition of the target
DNA sequence (Knauert and Glazer, 2001; Vasquez and
Glazer, 2002). A small-fragment homologous replace-
ment strategy utilized a 500 base single-stranded DNA to
generate a homologous replacement in mammalian cells
(Goncz et al, 1998, 2002). A recent innovation is the use of
adeno-associated viral vectors, which have a single-strand-
ed DNA genome, to modify homologous chromosomal se-
quences (Russell and Hirata, 1998). Although each of these
methods was shown to work in limited cases, the low ab-
solute frequency of homologous recombination remains a
serious limitation.
My laboratory has focused on the development of an
experimental strategy that centers on the site-specific cor-
rection of single-point mutations by using chimeric RNA–
DNA oligonucleotides (RDO) and relatively short single-
stranded oligodeoxynucleotides (ODN). One objective is
to establish reliable, sensitive, and standardized assays to
measure frequencies of gene repair and to use these assays
in mechanistic studies (Igoucheva et al, 1999, 2000, 2001,
2002, 2003). Such studies have become critical for under-
standing the gene repair process and setting realistic ex-
pectations on the capability of this technology. The other
objective is the application of gene repair toward potential
gene therapy in the epidermis (Alexeev and Yoon, 1998;
Alexeev et al, 2000, 2002). The epidermis is an ideal tissue
where oligonucleotides can be administered locally and the
treated sites can be monitored easily. In renewing tissues
such as the epidermis, a gene therapy approach must be
Abbreviations: ODN, oligodeoxynucleotides; RDO, RNA–DNA
oligonucleotides
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targeted toward the stem cell population and should require
identification, enrichment, and targeting of stem cells to
ensure the continued presence of the corrected gene. Ep-
idermal gene therapy is in an early stage and yet holds great
promise for its ultimate clinical application.
Structure of Targeting Oligonucleotides
RNA–DNA chimeric oligonucleotide An oligonucleotide
composed of a contiguous stretch of RNA and DNA resi-
dues was developed to facilitate correction of single-base
mutations in mammalian cells (Yoon et al, 1996). The original
design of the chimeric RDO consisted of a double-hairpin
capped duplex comprising a 25-nucleotide-long DNA
stretch (DNA-strand) containing the mismatch, paired to a
fully complementary 20-O-methyl RNA stretch (RNA-strand)
with a pentameric DNA interruption in the middle (Fig 1A). In
order to protect the molecule from RNase H and exonuc-
lease, ribose sugars were 20-O-methylated and RDO was
folded into a double-hairpin structure containing four T res-
idues in each loop and a five-base-pair GC clamp.
Mechanistic studies from our group and others showed
that the DNA-strand of RDO is responsible for the gene
repair activity (Gamper et al, 2000b; Igoucheva et al, 2001).
Extension of DNA by recombinase is considered to be crit-
ical for homology search and this extension is not possible
for RNA because of the 20 hydroxyl group in the RNA (Shi-
bata et al, 2001). Indeed, strand-pairing reactions indicated
that RNA was a poor substrate for recombination (Kirkpa-
trick and Radding, 1992). Thus, RDO is expected to have a
lower stand paring activity than single-stranded DNA (ODN).
On the other hand, the RNA-strand of RDO was shown to
stabilize a putative intermediate made by RecA substrates
(Gamper et al, 2000a). RDO made a stable intermediate
(double D-loop) whereas ODN made a very unstable inter-
mediate (D-loop) that dissociated rapidly (Fig 1A). But the
question remains whether one can extrapolate the conclu-
sions drawn from the RecA studies toward understanding
the mechanism of ODN-directed gene correction in living
cells. In contrast to the RecA studies, our mechanistic
studies indicate that ODN made stable intermediates via
resection of D-loops by nucleases present in mammalian
cells (Fig 1B) (Igoucheva et al, 2002, 2003).
Single-stranded oligodeoxynucleotides In the 1980s,
several groups reported that homologous ODN of 20–70
nucleotides containing a single mismatch to the target DNA
caused a sequence-specific alteration in mammalian cells
and yeast (Simon and Moore, 1987; Moerschell et al, 1988;
Campbell et al, 1989; Yamamoto et al, 1992). The large
variation in frequencies of gene alteration made it difficult to
use RDO in mammalian cells in a reproducible manner and
prompted the use of ODN. In light of the structure–activity
result that the DNA-strand of RDO was responsible for DNA
repair, the use of ODN in gene modification has been re-
examined (Gamper et al, 2000b; Igoucheva et al, 2001).
Modifications were made to protect both ends of ODN from
exonuclease degradation by incorporation of three to four
residues of 20-O-methyl RNA or phosphorothioate residues.
ODN with the 20-O-methyl RNA modification were shown to
alter target DNA sequences in reaction with mammalian
nuclear extracts, in the episomes and chromosomes of
mammalian cells (Igoucheva et al, 2001). It was also shown
that the gene correction rate in living cells was highly
Figure1
Oligonucleotide repair strategies. (A) The chimeric RNA–DNA
oligonucleotide (RDO) consists of a double-hairpin-capped duplex
comprising a 25-nucleotde long DNA stretch (DNA-strand) containing a
mismatch to the base present in the target DNA (red) and a fully com-
plimentary 20-O-methyl RNA stretch (RNA-strand). Two different models
are presented. One model predicts the formation of a double D-loop
between a RDO and the homologous target DNA, based on the RecA
studies (top panel). The stability of double D-loop is attributed to the
RNA-strand. Another model predicts the processing of a RDO by nuc-
leases and/or helicases and the strand pairing of the exposed active
domain of RDO (DNA-strand) to the targeted sequence, based on the
mechanism studies in mammalian cells (bottom panel). (B) The initial
step for gene correction by single-stranded oligodeoxynucleotide
(ODN) is postulated to be the formation of a joint molecule (D-loop).
Subsequently, a D-loop is further processed to a resected D-loop by
nuclease cleavages. According to this model, ODN has a better strand
pairing activity and makes a more stable intermediate than RDO.
Table I. Comparison of gene-targeting vectors
Mechanism Frequency Application
Double-stranded DNA HRþ selection 106–105 ES cells, knockout mouse
Triplex DNA TriplexþDNA repair 104–102 Targeted mutagenesis
Small fragment replacement HRþDNA repair 103–102 Correction of point mutations and large insertions and deletions
AAV-mediated gene targeting HRþDNA repair 105–102 Correction of point mutation and large insertion and deletions
RNA—DNA oligonucleotide HRþDNA repair 105–101 Repair of point and frameshift mutations
Single-stranded oligonucleotide HRþDNA repair 104–103 Repair of point and frameshift mutations
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dependent on the length and polarity of ODN. The highest
activity was shown by an ODN in antisense orientation with
a homology length of 45 nucleotides containing a mismatch
in the middle to the targeted sequence. These results led us
to propose a link between transcription and gene repair in
mammalian cells (Igoucheva et al, 2001). These findings
were later confirmed in yeast (Liu et al, 2002).
Oligonucleotide-Directed Gene Repair
in Mammalian Cells
The feasibility of gene correction by RDO was first demon-
strated in 1996 by correction of a point mutation in alkaline
phosphatase cDNA in CHO cells (Yoon et al, 1996). Gene
correction restored enzymatic activity; thus enabling visu-
alization of cells that gained the alkaline phosphatase pos-
itive phenotype as red cells. Moreover, gene correction was
confirmed by both functional enzyme activity and DNA
sequence. This study provided the basis for subsequent
applications of RDO for modification of chromosomal
genes. Since then, RDO has been shown to either correct
or cause a specific point mutation in episomal and genomic
DNA in mammalian cells, yeast, and plants (Liu et al, 2003;
Igouchev et al, in press; Kren and Steer, 2002). Gene repair
has also been reported in vivo in a variety of tissues in-
cluding the liver, lung, muscle, and skin. Frequencies ap-
proaching 40% reported in several studies (Kren et al, 1998)
have created expectations that oligonucleotide-directed
gene repair would be a quick and easy method to use
without selection procedures. It has become clear that the
reported high frequencies were caused by artifacts as a
result of assays solely based on PCR analysis. The very
reagents used for gene-targeting experiments are nucleic
acids containing the base for the desired alteration. These
molecules are degraded inside the cell and contaminate the
preparation of genomic DNA. During amplification, these
fragments are incorporated into the PCR products, thus
erroneously inflating the frequency of correction (Yoon et al,
2002). In light of these difficulties, functional assays scoring
phenotypic changes upon gene correction has become
critical to measure the frequencies in different target cells
reproducibly.
Importance of functional assays Reliable, sensitive, and
standardized assays played a critical role in the measure-
ment of gene correction frequency among different cell
types and in evaluating the structure–activity relationship of
oligonucleotides (Igoucheva et al, 1999; Igoucheva et al,
2002). Toward these goals, two assay systems utilizing mu-
tant tyrosinase and mutant LacZ, have been established in
which phenotypic changes could be detected upon gene
correction. Both systems have provided clear evidence
of gene correction by RDO and ODN in the episome and
chromosome of several mammalian cells: melanocytes
(Alexeev and Yoon, 1998; Alexeev et al, 2002), CHO-K1
(Igoucheva et al, 1999, 2000, 2001, 2003), primary human
keratinocytes (Yoon et al, 2002), and mouse embryonic
stem cells (Pierce et al, 2003).
In 1998, we demonstrated that an RDO corrected a point
mutation in murine tyrosinase gene, resulting in inheritable
restoration of enzymatic activity, melanin synthesis, and
pigmentation changes in albino melanocytes by using clon-
al analysis (Alexeev and Yoon, 1998). Use of natural
pigmentation in gene conversion studies offers a distinct
advantage over other strategies: live cells can be monitored
for pigmentation change, cloned, and characterized by their
genotype. Two important aspects of this study were: (i)
permanent genotypic and phenotypic changes were verified
by clonal analysis of the corrected cells and (ii) this was the
first report documenting a large variation in the level of gene
alteration by RDO using the same system. Among 100 ex-
periments performed, only three yielded a high frequency
approaching 15% of gene correction. Appearance of pig-
mented cells was detected in only 10% of experiments.
How can one explain the large variation observed in RDO-
mediated gene repair in a given cell line and the same lot of
synthesized RDO? The delivery and quality of RDO, two
favorite candidates for the reported variation among differ-
ent systems, are not sufficient to contribute the large var-
iation seen in our experiments. We propose that
the active domain (DNA-strand) needs to be exposed at
the right time and at the right locale to the target DNA for
successful gene correction (Fig 1A). Since the processing of
RDO by nucleases or helicases to expose the active domain
is random, the subsequent strand-pairing reaction to the
target DNA is also random and difficult to control.
Relying on the pigmentation change, RDO and ODN
were compared in correcting the tyrosinase gene in albino
melanocytes (Alexeev et al, 2002). The frequency of ODN-
directed gene alteration (2  1041  103) was com-
parable with RDO. ODN, however, showed much more
reproducible gene correction rates than RDO. Furthermore,
ODN exhibited a consistent frequency of gene correction in
the genome of CHO-K1 cells with an integrated mutant
LacZ gene (data from over 100 experiments). Other groups
also reported more consistent and higher gene repair rates
of ODN than RDO (Gamper et al, 2000b; Liu et al, 2001).
Also, ODN is easier to synthesize and thus would become
more accessible for researchers interested in using this
technology.
In 1999, we established a mutant LacZ vector that con-
tains a single point mutation in the LacZ gene (G1651A),
which results in a loss of enzymatic activity caused by an
amino acid substitution (E523K) (Igoucheva et al, 1999).
When cells containing this mutant reporter gene are cor-
rected by gene targeting, the enzymatic activity of the mu-
tant b-galactosidase is restored and corrected cells can be
visualized by histochemical staining. This mutant LacZ sys-
tem has been instrumental in developing gene repair strat-
egies by providing an easily detectable and measurable
marker for gene correction in biochemical studies using
nuclear extracts, episomes, and chromosomes of mamma-
lian cells (Igoucheva et al, 1999, 2000, 2001, 2002, 2003).
The mutant LacZ system has the sensitivity to measure a
low frequency because simple counting of the number of
the blue bacterial colonies or blue-stained mammalian cells
can be used to score gene correction event.
Delivery of ODN to tissue culture cells Chemical or
physical means of gene delivery are attractive alternatives
to viral vectors for gene therapy since they appear to be
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relatively safe and do not place size limitations on the ther-
apeutic agent (Niidome and Huang, 2002). But efficient
delivery of macromolecules, such as nucleic acids and
proteins, to the right locale has been difficult to achieve so
far. The use of liposomes as delivery agents for DNA and
other polynucleotides is a natural extension of their appli-
cation as drug delivery agents. The use of positively
charged liposomes reduces the negative charges of the
DNA molecule facilitating its delivery through the cell mem-
brane. DNA also induces cationic liposome fusion, perhaps
by bridging two liposomes, drawing them closer and de-
stabilizing the bilayer. This fusogenic property provides the
opportunity for the DNA to enter the new liposome, or to
associate with the net negative charge on a cell membrane
to deliver their DNA. The efficiency of liposome delivery
appears to depend on many variables: cell type; lipid mem-
brane composition; relative ratio of the lipid to DNA; end-
ocytosis of ODN; release of ODN from endosome; nuclear
transfer; and the stability of the DNA–lipid complex during
these processes. Delivery of ODN requires optimization for
each cell type by testing many available liposomes. It has
been difficult to deliver ODN by liposome to the majority
of human primary cells. In contrast, highly efficient delivery of
ODN was achieved in human primary keratinocytes, even in
the absence of liposome (Nestle et al, 1994). Keratinocytes
have the ability to take up ODN probably by receptor-
mediated endocytosis or macropinocytosis. The exposure
of normal human keratinocytes to ODN induced expression
of several genes, including IL-1a and follistatin in a non-
sequence-specific manner (Mirmohammadsadegh et al,
2002). The mechanism of this efficient ODN delivery in ker-
atinocytes has not yet been fully elucidated although inter-
nalized ODN has been speculated to bind to an intracellular
receptor (e.g., Toll-like receptor 9), which mediates signaling.
Frequency of gene targeting in mammalian cells Initially,
efficient ODN-directed gene alteration in keratinocytes was
expected since large amounts of ODN can be delivered to
the nucleus. Keratinocytes in tissue culture, however, ex-
hibited a very low level of gene correction by ODN. In 1998,
we reported that human primary keratinocytes did not show
any detectable level of gene conversion by PCR-based
RFLP analysis (Santana et al, 1998). In 2001, another group
communicated the failure of gene targeting in human ker-
atinocytes (van der Steege et al, 2001). The primary reason
for these failures is that assays used to detect gene repair,
the PCR-based RFLP analysis by us and the immunofluo-
rescence by van der Steege et al, are simply not sensitive
enough to detect the low frequency of gene alteration. To
measure a low frequency, human primary keratinocytes
were transduced by a retrovirus containing the mutant
LacZ. Using these keratinocytes, a low level of gene cor-
rection in human keratinocytes, 5–10 blue cells per 106
cells, was observed, in spite of their efficient nuclear uptake
of oligonucleotide (Yoon et al, 2002).
If oligonucleotides are to be used for gene targeting, how
can we make it more practical? Low rates of homologous
recombination, on the order of 105, were overcome by the
ingenious use of selectable markers in gene-targeting vec-
tors (Capecchi, 1989). But it has been difficult to devise a
general selection strategy, because positive and negative
selections used in gene-targeting vectors cannot be incor-
porated into ODN. We hypothesized that cells competent in
ODN-mediated alteration of one gene might also be com-
petent in alteration of another gene. Based on this concept,
a selection strategy was developed to identify cells that
have undergone a gene modification by the use of two ODN,
one targeting a gene of interest and the other targeting a
defective selectable marker gene that manifests a pheno-
typic change upon gene alteration. Our results indicate that
if two oligonucleotides are present within the nucleus of a
‘‘repair-competent’’ cell, then dual targeting events could
possibly occur with a relatively high frequency (Alexeev et al,
2002). Thus, the absolute frequency remains at the same
level, but the probability of finding cells with the desired
gene alteration is increased by first selecting cells according
to the phenotypic change. This exemplifies one approach to
overcome the low frequency of gene correction, which is
essential to make this technology more applicable.
Oligonucleotide-Directed Gene Repair
in Animal Model
In vivo delivery The epidermis is well suited to many
localized in vivo delivery methods including topical
application, intradermal injection, gene gun and in vivo
electroporation. Topical application of the cationic lipo-
some–DNA mixture to mouse skin in the anagen stage of
hair cycle resulted in efficient in vivo DNA delivery to hair
follicles (Alexeev et al, 2000; Domashenko et al, 2000). Top-
ical application of antisense ODN in ointments resulted in a
rapid and prolonged uptake in keratinocytes in the epider-
mis (Mehta et al, 2000). Short oligomers of arginine attached
to a variety of small molecules showed efficient delivery of
these conjugates into the epidermis, overcoming the stra-
tum corneum barrier (Wender et al, 2000).
Gene gun delivery utilizes an adjustable electric dis-
charge to generate a shock wave which accelerates DNA-
coated gold particles into target cells or tissues, resulting in
gene transfer (Lin et al, 2000). These gold particles can
penetrate through the cell membrane, carrying the bound
DNA into the cell by a receptor-independent pathway. Gene
gun delivery of the reporter plasmid encoding LacZ gene
resulted in dermal expression (Williams et al, 1991) and a
promoter-specific expression in skin (Lin et al, 2001). In vivo
gene gun delivery, however, is limited by the degree of
penetration into the tissue and transient expression.
Combining electroporation in vivo together with intra-
muscular injection of plasmid DNA enhanced gene expres-
sion much higher than the intramuscular injection alone
(Aihara and Miyazaki, 1998). By using various types of elec-
trodes, efficiency of gene transfer was further increased,
resulting in 100–10,000-fold increases in expression (Mir
et al, 1999). During electroporation, multiple pulses are de-
livered to the target area where DNA is pre-injected. The
introduced electric field causes transient pores in the cell of
the tissue and allows uptake of molecules into the cells.
Delivery of the reporter plasmid encoding LacZ gene by
electroporation to hairless mice showed extensive expres-
sion of b-galactosidase in the dermis and hair follicles
(Maruyama et al, 2001; Zhang et al, 2002).
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To determine the most efficient delivery method, fluo-
rescein-conjugated oligonucleotides were complexed with
liposomes and delivered to murine skin (Alexeev et al, 2000).
The intensity and localization of fluorescence was com-
pared among different methods. Fluorescence was detect-
ed in the epidermis and hair follicles upon topical
application (Fig 2A). Intradermal injection resulted in much
more intense fluorescence than topical application in the
dermis and hair follicles, but not in the epidermis (Fig 2B).
The in vivo electroporation method increased efficiency of
ODN delivery more than a 1000-fold, in comparison to the
intradermal injection alone (Fig 2C). The fluorescence was
distributed evenly through the epidermis as well as the de-
rmis in the injected area and associated with all compo-
nents of hair follicles. Thus, each method delivers a different
amount of ODN to different compartments of skin.
In vivo gene correction In contrast to the low level of gene
correction by RDO and ODN in cultured keratinocytes, a
much higher level of genotypic correction was observed
from the skin biopsies in vivo (Alexeev et al, 2000). Five
intradermal injections of RDO designed to correct a single
point mutation in the tyrosinase gene of albino BALB/c
mouse skin resulted in 20–30 pigmented hairs per 25 mm2
injected area that contains approximately 1000 hair follicles,
indicating phenotypic correction of 2%. In contrast, DNA
sequence analysis of the same skin biopsies from the 5-
mo-old mice exhibited 5%–30% of gene correction. It is
reasoned that the large discrepancy between phenotypic
and genotypic correction frequency could arise from the
unique regenerating property of epidermis: (i) keratinocytes
represent the majority of cells in skin and the regenerating
property of skin comes from the stem cells of keratinocytes;
(ii) melanocytes are very specialized cells involved in pig-
mentation, consisting of less than 1% of the cells in skin; (iii)
because the tyrosinase gene is transcribed exclusively in
melanocytes and not in other cells, the corrected keratin-
ocytes will not express tyrosinase nor make melanin; (iv)
phenotypic change represents the number of corrected
melanocytes, whereas genotypic change represents the
genetic alteration in all cells in skin; and (v) since keratin-
ocytes constitute the majority of skin cells, the frequency
of genotypic correction in skin biopsies reflects that of
keratinocytes.
How can keratinocytes, which exhibit a low-level gene
correction in tissue culture condition, manifest a high level in
vivo? One possibility is that high frequencies are generated
by the multiple injections performed during a 5-mo-period.
Repetitive injections, however, can cause at most a linear
increment and are not sufficient to explain the observed
high frequencies. Another possibility is that oligonucleotides
are capable of gene correction of epidermal stem cells and
expansion of the corrected stem cells may result in an ap-
parent high-level and long-lasting gene repair in epidermis
that has been observed.
To test whether in situ application of oligonucleotides can
alter genes in epidermis, RDO and ODN were made to in-
troduce a dominant mutation in the keratin 17 gene and
administered to neonatal murine skin by multiple intrader-
mal injections. In the injected areas, several morphological
changes were observed, consisting of twisted hair shafts,
broken hair follicles at the sebaceous gland level, occa-
sional rupture of hair bulb, and epidermal cysts (Fan and
Yoon, 2003). There phenotypic changes are remarkably
similar to those found in the K17 null mice (McGowan et al,
2002), but transient either due to the compensation of K17
by other keratins or the replacement of the mutated cells
by the normal surrounding cells during hair growth. These
results indicate that in situ application of oligonucleotides
to skin can produce genotypic and phenotypic changes
in keratinocytes (Fan and Yoon, 2003), as well as in me-
lanocytes (Alexeev et al, 2000). If the rate of gene alteration
can be improved, oligonucleotide-directed gene repair may
have an impact in cutaneous gene therapy.
Mechanism of ODN-Directed Gene Targeting
The initial step for gene correction by oligonucleotides was
postulated to be the formation of an intermediate joint mol-
ecule, in which an oligonucleotide is paired to the homol-
ogous DNA by proteins involved in recombination (Fig 1B).
The next step is the processing of intermediates by DNA
repair processes, leading to the correction of the target
sequence.
Formation of intermediates in gene repair process Strand
pairing has long been considered to be the rate-limiting step
in the process of gene correction by oligonucleotides. But
recent data from my laboratory indicated that this might not
be true in some cases (Igoucheva et al, 2002, 2003). Mech-
anistic studies utilized mammalian extracts to measure
strand pairing and gene correction activity simultaneously.
Mammalian nuclear extracts promoted strand pairing of
supercoiled DNA and its homologous oligonucleotides as
an initial step (Igoucheva et al, 1999). Contrary to the pre-
sumed notion that strand pairing is rate limiting, two nuclear
extracts (mouse embryonic fibroblasts isolated from iso-
genic p53þ /þ and p53/ mice) made the same amount of
joint molecules but showed vastly different functional gene
repair activity (Igoucheva et al, 2002). Another result also
supports the notion that strand pairing is not rate limiting in
Figure 2
Delivery of fluorescein-conjugated oligonuc-
leotides to murine skin. (A) Confocal fluo-
rescence micrograph of the frozen murine skin
section in which oligonucleotide was applied
topically, (B) injected intradermally, and (C) in vivo
electroporated after intradermal injection. Ab-
breviations: ep, epidermis; hf, hair follicle; dm,
dermis.
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episomal gene correction. When a known amount of pre-
formed intermediates were introduced into living cells, only
a very small fraction of these molecules achieved gene
correction (Igoucheva et al, 2003). Since these intermedi-
ates were relatively stable in living cells, the rate-limiting
step appears to be a subsequent reaction, rather than the
initial strand pairing. More studies are needed to investigate
the strand-pairing event of chromosome since the structure
of target is complex and affected by a milieu of biological
events.
Processing of intermediates in gene repair process A
bigger piece of the puzzle is the processing of joint mol-
ecules (D-loops), which leads to modification of the target
sequence. It has been postulated that the intermediate
would be further processed either by resolution of cross-
junctions and/or by DNA repair pathways. Because D-loops
contain mismatches to the target DNA, proteins involved in
DNA mismatch repair have been suggested to participate in
the processing of joint molecules. Contrary to this conven-
tional belief, recent data suggest that mismatch repair
in fact has an antagonistic effect in ODN-directed repair
(Dekker et al, 2003).
Perhaps more attention should be given to the structural
perturbation caused by D-loop formation rather than a mis-
match within the D-loop. Transient formation of a D-loop in
living cells could be considered as another class of DNA
structural changes that can elicit a plethora of DNA repair
activities. A clear example of such a phenomenon was
shown by TFO, which bind in the major groove of double-
stranded target with a minor structural change. In spite of
this minor structural change, TFO binding induced signifi-
cant increases in both DNA repair (nucleotide excision re-
pair) and recombination activities around the binding site
(Knauert and Glazer, 2001). In comparison, D-loop forma-
tion is expected to make a much greater change in base
stacking, tilting, and thus creating considerable torsional
stress at both junctions. What is clearly emerging is that
ODN can cause a transient but major structural change in
DNA, which in turn elicits multiple DNA repair pathways in
conjunction with transcription and replication.
Transcription affects both formation and processing of
intermediates Recently, importance of transcription in
gene repair by ODN was shown in mammalian cells in both
episome and chromosome (Igoucheva et al, 2001, 2003).
During this study several important observations have been
made: (i) gene repair by ODN occurs much more efficiently
when the target gene is actively transcribed; (ii) antisense is
more active than sense ODN when the gene is actively
transcribed; and (iii) a point mutation in transcriptionally re-
pressed genes cannot be efficiently repaired by ODN.
These results imply that one needs to select actively tran-
scribing genes for ODN-directed gene targeting and are in
agreement with conclusions made in yeast (Liu et al, 2002).
The mechanism linking gene repair and transcription was
investigated by combining a biochemical approach and a
cell-based assay to measure the functional activity of inter-
mediates (Igoucheva et al, 2003). Transcription plays a role
in both formation and processing of intermediates but in the
opposite direction (see Fig 3). Transcription favors the for-
mation of intermediate by antisense ODN. The non-tran-
scribed strand DNA present in the transcriptional bubble is
accessible for strand pairing by antisense ODN, whereas
the transcribed strand is occupied with the RNA poly-
merase complex, limiting strand pairing by sense ODN.
On the other hand, transcription favors the processing of
Figure3
Hypothetical model for ODN-directed gene repair. (A–C) During
transcriptional elongation, a portion of the non-transcribed strand
forms a transcription bubble that is accessible for the strand pairing by
antisense ODN to form a D-loop. In contrast, the transcribed strand is
occupied by the RNA polymerase complex (RNAP), limiting the ac-
cessibility of sense ODN to the transcribed strand. (D) During the
next round of transcription, trafficking of RNAP is interrupted by the
presence of the D-loop. (E) The D-loop is converted to the resected
D-loop by nucleases. (F) The presence of stalled RNAP may serve as
a signal to direct the repair to the transcribed strand. (G) Restoration
of transcription.
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intermediate formed by sense ODN, suggesting that ODN-
directed gene repair may be linked to transcription-coupled
repair. When DNA damage occurs in the transcribed strand,
transcriptional elongation is arrested and the presence of
stalled RNA polymerase at a lesion on the transcribed
strand serves as a signal to direct repair to the transcribed
strand. The central role in the recruitment of DNA repair
systems to the transcribed strand has been attributed to
transcription repair coupling factors, such as Cockayne
Syndrome A (CsA) and B (CsB), a family of ATPases with
chromatin remodeling activities (van Gool et al, 1997; Citte-
rio et al, 2000). These coupling factors displace the stalled
RNA polymerase transiently and recruit proteins involved in
DNA repair to the site of DNA damage (Citterio et al, 2000).
Multiple DNA repair systems are coupled to transcription,
including nucleotide excision repair, base excision repair
and mismatch repair. Thus, transcription plays an important
role in many different types of DNA repair pathway, perhaps
including ODN-directed repair pathway. Our recent studies
indicate that the primary reason for efficient gene repair
exhibited by the antisense ODN is an increased formation of
an intermediate during active transcription (Igoucheva et al,
2003). The enhanced activity of antisense ODN holds for
different mismatches, insertions and deletions (Igoucheva
et al, 2001; Liu et al, 2001), indicating a general transcrip-
tion-driven mechanism. This effect is remarkable since
antisense ODN can actually suppress the expression of the
corrected gene, thus lowering its apparent correction rate
when compared with the sense ODN.
Future Directions
A great potential for gene alteration will undoubtedly be in
stem cells. The epidermis continuously regenerates via di-
vision of keratinocytes that are renewed throughout the
adult life span by proliferation of epidermal stem cells. In
continually renewing tissues, the stem cell population is
present to provide a source of rapidly proliferating transit
amplifying and differentiating cells. Stem cells have both the
capacity for self-renewal, that is, the ability to generate ad-
ditional stem cells and thus be long-lived, and the capacity
to generate progeny that are fated to proliferate and differ-
entiate. During in vivo experiments, we found a surprisingly
high frequency of correction in skin biopsies and hy-
pothesized that oligonucleotides may be capable of gene
correction in epidermal stem cells. Transgenic mice that ex-
press a high level of the mutant b-galactosidase in epider-
mis, recently generated in my laboratory, will be ideal to test
this hypothesis. In addition, gene correction in epidermal
stem cells in the mutant LacZ mouse might mark the cells in
a similar manner as the retroviral marking of these cells
(Ghazizadeh and Taichman). Histological analysis of tissue
sections from these mice may yield information on the lin-
eages of epidermal stem cells.
A group of inheritable disorders characterized by fragility
of skin, epidermolysis bullosa, are caused by point muta-
tions in several genes maintaining the integrity of cutaneous
structure. Separation of tissue occurs between dermal and
epidermal junction, resulting in recurring painful blisters.
Mutations in some keratin genes cause cytolysis of kera-
tinocytes. Thus, if one can correct genes in the epidermal
stem cells, corrected cells will have a proliferative advan-
tage and may compensate for the mutated cells. In this
case, a small percentage of the corrected target cells may
ameliorate the phenotype of disease. But with the ultimate
goal of treating human patients with genetic disease, we
must consider the issue of delivery. Topical formulation,
cationic lipid technology, electroporation, and ultrasonic
deliveries are promising experimental techniques but need
further improvements. The accessibility of the epidermis
presents an opportunity to test many localized administra-
tion methods and monitor phenotypic changes.
Mechanistic studies to identify the rate-limiting step and
critical proteins involved in the gene correction process
continue to play an important role in the development of
ODN-directed gene alteration. Introduction of a specific
double-strand break at the targeted loci and modulation of
cellular activities to increase homologous recombination will
be necessary to make ODN-directed gene alteration prac-
tical. We are constantly reminded that the expectation of
oligonucleotide-directed gene repair as ‘‘a quick and easy
method to use without selection procedures’’ was generat-
ed by initial studies lacking solid mechanistic understand-
ing. Systematic mechanistic studies together with the
development of reliable, sensitive, and standardized assays
to measure gene correction are essential to develop this
technology for the practical use.
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